These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11489835)

  • 1. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
    Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
    Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
    Kondraganti S; Mohanam S; Chintala SK; Kin Y; Jasti SL; Nirmala C; Lakka SS; Adachi Y; Kyritsis AP; Ali-Osman F; Sawaya R; Fuller GN; Rao JS
    Cancer Res; 2000 Dec; 60(24):6851-5. PubMed ID: 11156378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
    Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
    Krueger S; Haeckel C; Buehling F; Roessner A
    Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.
    Mohan PM; Chintala SK; Mohanam S; Gladson CL; Kim ES; Gokaslan ZL; Lakka SS; Roth JA; Fang B; Sawaya R; Kyritsis AP; Rao JS
    Cancer Res; 1999 Jul; 59(14):3369-73. PubMed ID: 10416596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Lakka SS; Jasti SL; Gondi C; Boyd D; Chandrasekar N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2002 Aug; 21(36):5601-8. PubMed ID: 12165859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
    Tavian D; Salvi A; De Petro G; Barlati S
    Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
    Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
    Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
    Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
    Konduri SD; Yanamandra N; Siddique K; Joseph A; Dinh DH; Olivero WC; Gujrati M; Kouraklis G; Swaroop A; Kyritsis AP; Rao JS
    Oncogene; 2002 Dec; 21(57):8705-12. PubMed ID: 12483523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro suppression of urokinase plasminogen activator in breast cancer cells--a comparison of two antisense strategies.
    Arens N; Gandhari M; Bleyl U; Hildenbrand R
    Int J Oncol; 2005 Jan; 26(1):113-9. PubMed ID: 15586231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
    Zhang X; Fei Z; Bu X; Zhen H; Zhang Z; Gu J; Chen Y
    J Surg Oncol; 2000 Jun; 74(2):90-4. PubMed ID: 10914816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.